We are live on ! Find out more
IRD

Opus Genetics
IRD

38 hedge funds and large institutions have $5.65M invested in Opus Genetics in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

23% more funds holding

Funds holding: 31 → 38 (+7)

1% less capital invested

Capital invested by funds: $5.71M → $5.65M (-$63.4K)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

Holders
38
Holders Change
+7
Holders Change %
+22.58%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
8
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$191K
2
Morgan Stanley
Morgan Stanley
New York
+$181K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$167K
4
Renaissance Technologies
Renaissance Technologies
New York
+$112K
5
Wells Fargo
Wells Fargo
California
+$96.7K

Top Sellers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
-$43.9K
2
CCM
Condor Capital Management
New Jersey
-$41.1K
3
Goldman Sachs
Goldman Sachs
New York
-$25.9K
4
Bank of America
Bank of America
North Carolina
-$21.8K
5
Citadel Advisors
Citadel Advisors
Florida
-$12.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.04M +$167K +485 +6%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$641K – – –
VKH
3
Virtu KCG Holdings
New York
$243K +$191K +553 +325%
Wells Fargo
4
Wells Fargo
California
$210K +$96.7K +280 +81%
Morgan Stanley
5
Morgan Stanley
New York
$176K +$181K +525 New
Northern Trust
6
Northern Trust
Illinois
$164K – – –
AQR Capital Management
7
AQR Capital Management
Connecticut
$150K – – –
BCM
8
Bridgeway Capital Management
Texas
$126K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$108K +$112K +323 New
NFC
10
Northeast Financial Consultants
Connecticut
$105K – – –
Bank of New York Mellon
11
Bank of New York Mellon
New York
$90K – – –
CCM
12
Condor Capital Management
New Jersey
$85K -$41.1K -119 -32%
Goldman Sachs
13
Goldman Sachs
New York
$85K -$25.9K -75 -23%
BMC
14
Benin Management Corp
Connecticut
$58K – – –
UBS Group
15
UBS Group
Switzerland
$37K +$38.3K +111 New
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$36K +$36.9K +107 New
Bank of America
17
Bank of America
North Carolina
$35K -$21.8K -63 -38%
BIT
18
BlackRock Institutional Trust
California
$35K +$36.6K +106 New
Deutsche Bank
19
Deutsche Bank
Germany
$30K -$43.9K -127 -58%
BA
20
BlackRock Advisors
Delaware
$25K – – –
State Street
21
State Street
Massachusetts
$23K -$2.76K -8 -11%
FHC
22
First Heartland Consultants
Missouri
$21K +$14.5K +42 +200%
GC
23
Guggenheim Capital
Illinois
$19K +$5.87K +17 +41%
ASN
24
Advisory Services Network
Georgia
$16K – – –
Commonwealth Equity Services
25
Commonwealth Equity Services
Massachusetts
$16K – – –
1
2

IRD Hedge Fund Activity: Q4 2014 in Review

38 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2014, worth a combined $5.65M — down 1.1% from $5.71M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new IRD positions and 1 closed out — a net gain of 7 holders — while 5 added to existing stakes and 8 trimmed.

The largest buyer was Virtu KCG Holdings, adding an estimated $191K. The largest seller was Deutsche Bank, cutting an estimated $43.9K.

  • 38 institutional investors held Opus Genetics (IRD) as of Q4 2014, up from 31 in Q3 2014.
  • Funds reported $5.65M of Opus Genetics stock for Q4 2014, down 1.1% quarter-over-quarter.
  • 8 funds opened new Opus Genetics positions in Q4 2014 and 1 closed out, a net change of +7 holders.
  • The largest Opus Genetics buyer in Q4 2014 was Virtu KCG Holdings, an estimated $191K added.
  • The largest Opus Genetics seller in Q4 2014 was Deutsche Bank, an estimated $43.9K sold.

Based on aggregated 13F filings for Q4 2014.